YONGTAI TECH.(SZ:002326)2022-11-19 03:42Group 1: Financial Performance - In 2021, the revenue from pesticide products was 452.576 million RMB, accounting for 10.13% of total revenue [1] - In Q1 2022, the company achieved a revenue of 1.7373 billion RMB and a net profit of 389.7815 million RMB, with significant growth attributed to the lithium battery materials segment [2] - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares based on the total share capital of 876,566,295 shares as of December 31, 2021 [5] Group 2: Business Segments - The revenue breakdown for 2021 was as follows: pharmaceutical segment 26.14%, pesticide segment 10.13%, lithium battery and other materials segment 26.03%, and trading segment 36.81% [5] - The company is focusing on developing the pharmaceutical and lithium battery materials sectors, leveraging core technologies in fluorinated intermediates and chiral enzyme catalysis [5] Group 3: Production and Capacity - The company currently has a production capacity of 8,000 tons/year for lithium hexafluorophosphate, 5,000 tons/year for VC, and 3,000 tons/year for FEC [7] - The construction period for the lithium battery materials projects is approximately 1 year, with ongoing projects expected to be operational by the end of 2022 [7] Group 4: Market Strategy and Risk Management - The company is closely monitoring market price fluctuations and will implement cost-reduction strategies through technological improvements to maintain profitability [2] - The company emphasizes long-term development and value creation for investors, aiming to enhance profitability and strengthen investor relations [2] Group 5: Research and Development - Currently, the company has no plans for vaccine development or acquisition of lithium mines, focusing instead on upstream electrolyte and related materials [3] - The company is investing in the production capacity of sodium-ion battery materials, with a planned capacity of 250 tons [3]